Please login to the form below
bortezomib
This page shows the latest bortezomib news and features for those working in and with pharma, biotech and healthcare.
J&J’s Darzalex shows ‘significant’ survival benefit in newly diagnosed multiple myeloma
However, Sanofi is currently evaluating Sarclisa in combination with Velcade (bortezomib), Revlimid and dexamethasone in newly diagnosed multiple myeloma patients who are not eligible for transplant.
Latest news
-
Janssen scores another expansion for new Darzalex combination in the US
Janssen has been expanding the use of Darzalex with a number of combination therapies, including its recently approved Darzalex, bortezomib, thalidomide and dexamethasone (VTd) combination.
-
In virtual meeting, CHMP backs Sanofi’s myeloma drug Sarclisa
Velcade (bortezomib), and have disease progression.
-
After FDA refusal, Takeda builds case for subcutaneous Entyvio
growth back on track after losing patent protection for its big-selling multiple myeloma drug Velcade (bortezomib).
-
Janssen files new Darzalex combination for multiple myeloma
J&J has been expanding the use of Darzalex with a number of combination therapies, including its recently approved Darzalex, bortezomib, thalidomide and dexamethasone (VTd) combination.
-
FDA fast-tracks GSK’s anti-BCMA drug for multiple myeloma
bortezomib) and Johnson &Johnson’s anti-CD38 antibody Darzalex (daratumumab).
More from news
Approximately 5 fully matching, plus 93 partially matching documents found.
Latest appointments
-
Warp Drive Bio names Gregory Verdine as CEO
of cancer treatment Velcade (bortezomib).
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
What does the future hold for Light-chain Amyloidosis?
In the absence of approved therapies, the treatment strategy being adopted was very much aligned with that recommended for Multiple Myeloma, with Velcade (bortezomib), used in combination with cyclophosphamide and dexamethasone
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- New Omicron sub-variants cause COVID-19 cases to rise in the UK
- Sanofi Global Health unveils new nonprofit Impact brand
- Novartis announces positive phase 3 trial results for advanced oesophageal cancer
- Pfizer announces commitment to achieve Net-Zero Standard by 2040
- My journey advancing the science in pulmonary hypertension
- Dermavant publishes positive phase 3 data for treatment of plaque psoriasis
- The Power of AI in Medical Education
- First evidence-based guide launched to put patients at heart of digital innovations
- FDA grants Priority Review for Biogen and Eisai’s lecanemab for early Alzheimer’s disease
- New Swiss research reveals how Omicron evades the immune system
- Evoke Kyne Named Communiqué Communications Consultancy of the Year 2021
- Michael Grela Elected President of the Society for Health Communication
- Eli Lilly to supply US government with 150,000 additional doses of bebtelovimab
- A creative awakening – how pharma is bringing innovation to the patient journey
- EMA grants Bavarian Nordic access to PRIME scheme for RSV vaccine candidate
- NHS App to revolutionise digital health and care with major digital updates by 2023
- Pfizer/BioNTech, AZ vaccines effective against Delta COVID-19 variant after two doses
- Shionogi Europe and NHS England agree on antibiotic subscription model
PMHub
M3 (EU)
M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors...
Latest intelligence
- Five big changes in the healthcare comms landscape
- The world of healthcare has changed very greatly in the five years since The Difference Collective launched. Our agile model and talented team have enabled us to keep pace with...
- Early communications in Pharma: How effective pre-approval comms delivers launch success
- What communications are required for a successful launch...
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
